MedPath

To Study The Efficacy of Kalonji Vati With Krishnatil Kwath Ghanvati in Oligohypomenorrhoea

Phase 2
Conditions
Health Condition 1: N915- Oligomenorrhea, unspecified
Registration Number
CTRI/2023/05/052226
Lead Sponsor
Dr Mitali Dhaval Malgave
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All female Patients in the Age group of 18-35 yrs (married , unmarried ,

nulliparous, parous, multiparous ) who are willing to participate in the study

who are having symptoms of oligohypomenorrhoea.

2. Female patients irrespective of caste , income group and any occupation will be

selected

3.lntermenstrual duration more than 35 days

4.Menstrual bleeding flow less than 2 days.

5.BMI – 18-30

6.Clinically diagnosed K/C/O PCOD without metabolic syndrome.

7.All Patients who are having symptoms of Artavakshaya i.e. Yathochitkal Adarshan,

Alpata (Reduce Quntity as well as duration ),Yonivedana

Exclusion Criteria

1.Major systemic disease likely to influence menstrual cycle like HTN , DM , TB , HIV ,

Thyroid Disorder, Renal Disorders.

2.All dignosed K/C/O malignancy , cervical erosion , polyp , adenomyosis ,

Endometriosis, tubo ovarian mass, Pelvic inflammatory disease.

3.All dignosed K/C/O Premature Ovarian Failure

• HB <9 gm %

• Lactating woman

• Woman having IUCD

• PCOD With metabolic syndrome

4. Intermenstrual duration more than 60 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of Kalonji Vati and Krishnatil Kwath Ghanvati in <br/ ><br>Artavakshaya W.S.R. to OligohypomenorrhoeaTimepoint: 16 weeks
Secondary Outcome Measures
NameTimeMethod
1.To study in detail the Nidana Samprapti of Artavakshaya. <br/ ><br>2.To study etiopathology of <br/ ><br>oligohypomenorrhoea.Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath